Tennessee Oncology - Chattanooga - GHCR Site I

Chattanooga, Tennessee 37403

1 studies enrolling now · 1 studies all time

What they study most

Patients With Non-Small Cell Lung Cancer

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now